Company intelligence / Profile preview

Drug Screen

Ownership: Private
Development stage: Other

Overview

Drug Screen is a healthcare services and diagnostics company specializing in the provision of drug and alcohol testing solutions. The company provides a range of screening products and services, including onsite testing, laboratory analysis, and policy development for corporate and industrial clients. Their focus is on maintaining workplace safety and compliance through rapid and accurate detection of controlled substances. While primarily a service and diagnostic provider, they play a critical role in the healthcare ecosystem by managing substance abuse monitoring and occupational health standards.

Therapeutic areas: PsychiatryOther
Modalities: Diagnostic TestImmunoassay
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Drug Screen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drug Screen.

Explore the full profile